ICPT stock gains after patent settlement with Amneal (NASDAQ:ICPT)

Gratitude Concept With Heart Symbol


The shares of Intercept Pharmaceuticals (NASDAQ:ICPT) added ~8% on Wednesday after the biotech announced an agreement with generic drugmaker Amneal Pharmaceuticals (NYSE:AMRX) to settle a patent dispute over the liver disease therapy Ocaliva.

The Jan. 24 agreement aims to resolve aAMRXICPT

Source link

5 Trading strategies to make money

Looking to boost your trading profits?

Get you copy of our FREE Ebook Now !!!